Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

CITALOPRAM HYDROBRO

Awarded
SPE2DP26F6376Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Defense Logistics Agency award SPE2DP26F6376 was issued on June 5, 2026, to DMS Pharmaceutical Group Inc under the overarching delivery order SPE2DX25D9900. The contract was for the procurement of Citalopram Hydrobro, specifically two bottles at a unit price of 3.4400, resulting in a total initial contract value of 6.88 dollars. This order was managed by the DLA Troop Support Medical Supply Chain FSB as part of a larger commercial items framework. Subsequently, modification P00001 was signed on August 26, 2026, which served as a supplemental agreement to cancel the order. This modification cancelled CLIN 0001 and decreased the total contract amount from 6.88 dollars to 0.00 dollars. The cancellation was executed at no cost or liability to either the Government or the contractor, and the contractor accepted the terms, concluding all requirements for this specific order.

General Info

DLA award to DMS Pharmaceutical Group for Citalopram was cancelled at no cost.

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Not specified

Set-Aside

NONE

Documents

3

SPE2DP26F6376 P00001 Cancellation Modification

PDF, High priority: read this firstmodification
High

SPE2DP-26-F-6376 Order for Supplies or Services

PDF, Low prioritycontract-document
Low

SPE2DX-25-D-9900 SF 1449 Solicitation/Contract/Order

PDF, Low prioritycontract-document
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F6376 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: See Award Doc Award Date: 06-05-2026 Delivery order under: SPE2DX25D9900 Line items: - CITALOPRAM HYDROBRO (NSN/Part 6505015054632)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
International
Pralidoxime
Solicitation # W6369-26-A033/B
The Department of National Defence, through the Strategic Medical Countermeasures Program, is soliciting offers for the procurement of Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. The contract includes an initial requirement for 450 treatment courses to be delivered by March 31, 2027, with optional requirements for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. A treatment course is defined as 1 gram per day for seven days. The award will be granted to the compliant offer with the lowest evaluated price, based on Delivered at Place terms for the Central Medical Equipment Depot in Petawawa, Ontario. Technical requirements mandate that the product be manufactured according to current Good Manufacturing Practices and hold a Health Canada issued Notice of Compliance or appropriate authorization. The medication must have a minimum shelf-life of 36 months from the date of manufacture and be delivered in a temperature-controlled environment, specifically maintained between 2 to 8 degrees Celsius, with continuous electronic monitoring and a Certificate of Conformity provided upon delivery. All packaging and drug inserts must be available in English or French. There are no security requirements associated with this procurement, and the solicitation is open to Canadian suppliers and those of applicable trading partners.
Department of National Defence

POSTED

1 day ago

DEADLINE

in 20 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS